Brompheniramine, hydrocodone, and pseudoephedrine and Ranibizumab Intraocular
Determining the interaction of Brompheniramine, hydrocodone, and pseudoephedrine and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / hydrocodone / pseudoephedrine
Brand name: Bromplex HD, Endacof HC, Visvex, Drocon-CS, Anaplex HD, Bromph HD, BroveX HC, Bromcomp HC, J-Tan D HC, M-END, SymTan A
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brompheniramine, hydrocodone, and pseudoephedrine-Ranibizumab ophthalmic
- Brompheniramine, hydrocodone, and pseudoephedrine-Ranitidine
- Brompheniramine, hydrocodone, and pseudoephedrine-Ranitidine Capsule
- Brompheniramine, hydrocodone, and pseudoephedrine-Ranitidine Hydrochloride
- Brompheniramine, hydrocodone, and pseudoephedrine-Ranitidine Injection
- Brompheniramine, hydrocodone, and pseudoephedrine-Ranitidine Suspension
- Ranibizumab Intraocular-Brompheniramine, Pseudoephedrine, and Dextromethorphan
- Ranibizumab Intraocular-Brompheniramine, Pseudoephedrine, Dextromethorpan Syrup
- Ranibizumab Intraocular-Bromplex DM
- Ranibizumab Intraocular-Bromplex HD
- Ranibizumab Intraocular-BromSite
- Ranibizumab Intraocular-BromSite ophthalmic